Vital Farms, Inc.
VITL- Exchange
- Nasdaq
- Industry
- Food and Kindred Products
- SEC CIK
- 0001579733
In the last 90 days, Vital Farms, Inc. insiders filed 0 open-market purchases and 2 sales; 228 institutions reported holding it in 13F filings for Q2 2026, worth $421.5M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:18 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Dec 25, 2022 | Dec 26, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 14, 2024 | Mar 9, 2023 | Mar 10, 2022 |
| Revenue | $759.4M | $606.3M | $471.9M | $362.1M | $260.9M |
| Cost of revenue | $473.8M | $376.4M | $309.5M | $252.6M | $178.0M |
| Gross profit | $285.7M | $229.9M | $162.3M | $109.4M | $82.9M |
| Operating expenses | $197.3M | $166.4M | $129.1M | $107.3M | $82.8M |
| Selling, general and administrative | $159.4M | $133.9M | $101.7M | $77.2M | $57.9M |
| Operating income | $88.4M | $63.6M | $33.3M | $2.10M | $52.0K |
| Interest expense | – | – | $782.0K | $114.0K | $52.0K |
| Income tax | $25.0M | $14.2M | $6.63M | $1.60M | -$2.03M |
| Net income | $66.3M | $53.4M | $25.6M | $1.25M | $2.43M |
| EPS, basic | $1.49 | $1.25 | $0.62 | $0.03 | $0.06 |
| EPS, diluted | $1.44 | $1.18 | $0.59 | $0.03 | $0.06 |
| Weighted shares, basic | 44.6M | 42.8M | 41.2M | 40.6M | 40.0M |
| Weighted shares, diluted | 46.0M | 45.1M | 43.3M | 43.5M | 43.3M |
| Margins and growth | |||||
| Gross margin | 37.6% | 37.9% | 34.4% | 30.2% | 31.8% |
| Operating margin | 11.6% | 10.5% | 7.0% | 0.6% | 0.0% |
| Net margin | 8.7% | 8.8% | 5.4% | 0.3% | 0.9% |
| Revenue growth, year over year | +25.3% | +28.5% | +30.3% | +38.8% | +21.8% |
| Net income growth, year over year | +24.2% | +108.8% | +1,943.6% | −48.5% | −72.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Dec 25, 2022 | Dec 26, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 14, 2024 | Mar 9, 2023 | Mar 10, 2022 |
| Cash and equivalents | $48.8M | $150.6M | $84.1M | $12.9M | $31.0M |
| Accounts receivable | $67.8M | $54.3M | $39.7M | $40.2M | $26.9M |
| Inventory | $66.5M | $23.7M | $32.9M | $26.8M | $10.9M |
| Total current assets | $262.6M | $246.0M | $195.5M | $149.6M | $141.2M |
| Property, plant and equipment | $160.6M | $84.5M | $66.8M | $59.2M | $44.6M |
| Goodwill | $3.86M | $3.86M | – | $3.86M | $3.86M |
| Total assets | $518.7M | $359.3M | $275.2M | $214.7M | $189.9M |
| Accounts payable | $55.1M | $38.6M | $33.5M | $26.0M | $22.5M |
| Total current liabilities | $121.6M | $78.5M | $65.2M | $47.7M | $38.0M |
| Total liabilities | $167.5M | $90.0M | $82.5M | $56.3M | $38.2M |
| Shareholders' equity | $351.3M | $269.3M | $192.7M | $158.3M | $151.6M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Dec 25, 2022 | Dec 26, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 14, 2024 | Mar 9, 2023 | Mar 10, 2022 |
| Operating cash flow | $33.7M | $64.8M | $50.9M | -$8.10M | $16.3M |
| Capital expenditures | $82.0M | $28.6M | $11.5M | $10.5M | $16.7M |
| Free cash flow | -$48.2M | $36.2M | $39.4M | -$18.6M | -$386.0K |
| Depreciation and amortization | $9.25M | $9.26M | $7.92M | $5.44M | $3.54M |
| Stock-based compensation | $12.4M | $10.3M | $7.42M | $6.04M | $4.44M |
| Investing cash flow | -$134.3M | -$7.03M | $22.4M | -$10.0M | -$17.1M |
| Financing cash flow | -$1.23M | $8.65M | -$2.05M | $83.0K | $2.18M |
| Net change in cash | -$101.8M | $66.5M | $71.2M | -$18.1M | $1.42M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.6% | 1.7% | 1.6% | 1.7% | 1.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.